A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
一项 II 期随机、双盲、安慰剂对照研究，评估全人源抗 CXCL10 单克隆抗体 MDX-1100 与甲氨蝶呤联合治疗类风湿关节炎患者的疗效和安全性
期刊:Arthritis and Rheumatism
影响因子:11.4
doi:10.1002/art.34330
Michael Yellin, Igor Paliienko, Andra Balanescu, Semen Ter-Vartanian, Vira Tseluyko, Li-An Xu, Xiaolu Tao, Pina M Cardarelli, Heidi Leblanc, Geoff Nichol, Codrina Ancuta, Rodica Chirieac, Allison Luo
